Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study (Q40052920)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 June 2017

Language	Label	Description	Also known as
English	Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study	scientific article published on 9 June 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

multicenter clinical trial

0 references

0 references

Orthoebolavirus zairense

0 references

object named as

Eric A Sheldon

10

0 references

Thomas P. Monath

12

object named as

Thomas P Monath

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

D. Gray Heppner

1

object named as

D Gray Heppner

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Tracy L Kemp

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Brian K Martin

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

William J Ramsey

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Richard Nichols

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Emily J Dasen

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Charles J Link

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Rituparna Das

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Zhi Jin Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Teresa A Nowak

11

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

V920-004 study team

13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

9 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

854-866

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The cost of Ebola

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ebola virus vaccines: an overview of current approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

On closed test procedures for dose-response analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of platform technologies for assaying antibody to Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930313-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(17)30313-4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40052920&oldid=1883321395"